WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 9'955  9'976  9'996  10'015  10'031  10'224  10'385  10'759 
Births 98  98  98  98  97  96  126  153 
Surviving infants 98  98  98  97  97  95  124  150 
Pop. less than 5 years 493  491  490  490  489  494  615  877 
Pop. less than 15 years 1'461  1'458  1'460  1'467  1'478  1'719  2'117  2'366 
Female 15-49 years 2'362  2'368  2'374  2'382  2'393  2'560  2'533  2'577 

Number of reported case

(Click for retrospective incidence data for Hungary)
Diphtheria
Japanese encephalitis
Measles 29  1'198 
Mumps 223 
Pertussis 20  25  33  12  22 
Polio*
Rubella 107 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 10  25  48 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Hungary)
Vaccine year result method % card seen                                                
BCG          100  100  100  100  100  100  99  99 
DTP1          100  100  100  100  100  100 
DTP3          100  100  100  100  100  100  99  99 
HepB_BD         
HepB3         
Hib3          100  100  100  100  100  100 
JapEnc         
MCV          100  100  100  100  100  100  99  99 
MCV2          99  99  100  100  99  100 
PCV1          95  93  89  82 
PCV3          92  90  84 
Pol3          100  100  100  100  100  100  99  98 
Rota1         
Rota_last         
Rubella1          100  100  100  100  100 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Hungary)
BCG 99  99  99  99  99  99  99  99 
DTP1 99  99  99  99  99  99  99  99 
DTP3 99  99  99  99  99  99  99  99 
HepB3
HepB_BD
Hib3 99  99  99  99  99  99 
MCV 99  99  99  99  99  99  99  99 
MCV2 99  99  99  96  99  99 
PnC3 92  90  84 
Pol3 99  99  99  99  99  99  99  98 
Rota_last

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 3, 4, 18 months; Yes
HepB 13 years; Yes
MMR 15 months; 11 years; Yes
Pneumo_conj 2, 4, 15 months; Yes
Tdap 11 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2020  2010-2015  2006-2010  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 82  81 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 81  81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number 81  81  81  81  81 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number   81  81  81  81  81   
% of districts with MCV1 coverage >=95% From 0 to 100%   100  100  100  100  100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.